From: Changes in the gut bacterial communities in colon cancer surgery patients: an observational study
Characteristic | Frequency (%) or median (IQR) |
---|---|
Age (years) | 63.6 (56.4–76.3) |
Gender (female) | 12 (44.4) |
Body mass index (kg/m2) | 25.0 (22.6–27.3) |
Prealbumina (mg/l) | 270 (232–306) |
Preoperative blood glucose (mmol/l) | 5.7 (5.3–6.9) |
Preoperative haemoglobin (g/l) | 133 (113–145) |
Postoperative haemoglobin, day 3 (g/l) | 118 (105–122) |
MDR-GNB intestinal carriageb | |
None | 20 (74.7) |
ESBL | 3 (11.1) |
CRE and ESBL | 1 (3.7) |
Type of tumour | |
Adenocarcinoma | 24 (88.9) |
Neuroendocrine tumour | 2 (7.4) |
Non-resectable polyp | 1 (3.7) |
Tumour location | |
Ascending colon | 12 (44.4) |
Transverse colon | 2 (7.4) |
Descending colon | 7 (25.9) |
Sigmoid colon | 6 (22.2) |
TNM stage*c | |
T1 | 2 (7.4) |
T2 | 6 (22.2) |
T3 | 9 (33.3) |
T4 | 6 (22.2) |